Guardant Health partners with Quest for blood-based cancer screening
Go back to Guardant Health partners with Quest for blood-based cancer screening| Quest Diagnostics (NYSE: DGX) | Delayed: 195.00 -2.76 (1.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $197.76 | 52 Week High | $86.85 | |||
| Open | $196.69 | 52 Week Low | $59.66 | |||
| Day High | $197.44 | P/E | 36.72 | |||
| Day Low | $192.83 | EPS | $5.31 | |||
| Volume | 1,292,237 | |||||
| Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 131.78 +2.67 (2.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $129.11 | 52 Week High | $5.84 | |||
| Open | $132.48 | 52 Week Low | $5.49 | |||
| Day High | $134.00 | P/E | N/A | |||
| Day Low | $130.19 | EPS | $0.00 | |||
| Volume | 3,409,025 | |||||
